Ayele AG .2013 .Gebre-Selassie S. Prevalence and risk factors of hepatitis B and hepatitis C virus infections among patients with chronic liver diseases in public hospitals in Addis Ababa, Ethiopia. 2013 Jan, 3 : .
WHO | Hepatitis B,Merican I,Guan R,Amarapuka D,Alexander MJ,Chutaputti A,Chien RN .2000 .Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol, 15(12) : 1356-61.
Hepatitis . .B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virol. J. 2011 Mar, 6(1) : 1.
Ali SA,Donahue RM,Qureshi H,Vermund SH .2009 .Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. IJID, 13(1) : 9-19.
Barbacid M,Breitman ML,Lauver AL,Long LK,Vogt PK,Beemon K,Wang LH .1998 .Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature, (298) : 347.
Hepatitis B .2020 .. 2016 [cited 20 March, : .
Available ,pdf Foundation T. Hepatitis B Foundation: Managing HBV: Acute Hepatitis B,Bukhtiari N,Hussain T,Iqbal M,Malik AM,Qureshi AH,Hussain A .2020 .. 2016 [cited 20 March, : .
Hepatitis .2003 .B and C single and co-infection in chronic liver disease and their effect on the disease pattern. JPMA, 53(4) : 136-40.
.1995 .Beauty treatment and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy. Scand J Infect Dis, 27(5) : 441-4.
Foundation T. Hepatitis B Vaccine Information from Hepatitis B Foundation: ,Walker BR,Colledge NR,Ralston SH,Penman ID .2013 .Davidson's Principles and Practice of Medicine. 2016 [cited 23 March, : 948-52.
Wai CT,Lok AS .2002 .Treatment of hepatitis B. J Gastroenterol, 37(10) : 19-8.
Jafari S,Buxton JA,Afshar K,Copes R,Baharlou S. Tattooing .2012 .and risk of hepatitis B: a systematic review and meta-analysis. CJPH, : 207-12.
Mujeeb SA,Pearce MS . .Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan. BMC infectious diseases. 2008 Apr, 10(1) : 1.
Akbar N,Basuki B,Mulyanto B,Garabrant DH,Sulaiman A,Noer HM .1997 .Ethnicity, socioeconomic status, transfusions and risk of hepatitis B and hepatitis C infection. J Gastroenterol Hepatol, 12(11) : 752-57.
Dickson RC,Everhart JE,Lake JR,Wei YU,Seaberg EC,Wiesner RH . .Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology. 1997 Nov, 30(5) : 1668-74.
Toukan AU,Sharaiha ZK,Abu-El-Rub OA,Hmoud MK,Dahbour SS,Abu-Hassan HA .1990 .The epidemiology of hepatitis B virus among family members in the Middle East. Am J Epidemiol, 132(2) : 220-32.
Hagan H,Jarlais DC,Friedman SR,Purchase D,Alter MJ D .1995 .Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. AJPH, 85(11) : 1531-7.
Khattak MF,Salamat N,Bhatti FA,Qureshi TZ . .Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc, 52(9) : 398-402.
Polakoff S. .1986 .Acute hepatitis B in patients in Britain related to previous operations and dental treatment. Br Med J (Clin Res Ed), 293(6538) : 33-6.